National Institute for Health and Clinical Excellence: Acutely ill patients in hospital: Recognition of and response to acute illness in adults in hospital. NICE Clinical Guideline No. 50 [http://www.nice.org.uk/CG50]National Institute for Clinical Excellence: Acutely ill patients in hospital: ...
The article presents a summary of guidelines which have been developed by Great Britain's National Institute for Health and Clinical Excellence (NICE) for recognizing and responding to acute illness in hospitals. The guidelines, which were developed to help clinical staff better recognize and manage ...
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguardin...
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguardin...
1、Intravenous fluid therapy in adults in hospitalIssued: December 2013NICE clinical guideline 174.uk/cg174NICE has accredited the process used by the Centre for Clinical Practice at NICE to produce guidelines. Accreditation is valid for 5 years from September 2009 and applies to guide 2、lines ...
Nivolumab (Opdivo, Bristol-Myers Squibb)was not recommended in draft guidance for the adjuvant treatment of completely resected melanoma in adults with lymph node involvement or metastatic disease. An appraisal consultation document said there was uncertainty about the drug's clinical effectiveness. ...
Recognising and responding to acute illness in adults in hospital: summary of NICE guidance The article presents a summary of guidelines which have been developed by Great Britain's National Institute for Health and Clinical Excellence (NICE) for ......
A new targeted cancer drug was approved as an option for previously treated follicular lymphoma in adults. The new drug,lenalidomide(Revlimid, Celgene), interferes with cell processes to halt the growth of tumours and stop them from producing their own blood vessels. ...
(2007). Recognising and responding to acute illness in adults in hospital: summary of NICE guidelines. British Medical Journal; 335: 258-259.Armitage M, Eddleston J, Stokes T. Recognising and responding to acute illness in adults in hospital: summary of NICE guidance. BMJ. 2007; 335 :258...
The mean duration of illness in Gotaas et al. was 4.5 years (I-CBT, range: 0.5–14) and 5.3 years (CBT, range: 0.8–13). This might indicate that the two groups were not evenly matched, as people in the control group had been ill for longer. It also means that quite a few peo...